Pharmacy and Therapeutics (P&T) Committee
Background
The Pharmacy and Therapeutics (P&T) Committee is an advisory board established pursuant to Executive Order D004-07. The committee performs clinical reviews of drug classes and makes recommendations which help the Department develop and manage the Medicaid Preferred Drug List (PDL).
The P&T Committee is required to consider clinical criteria such as drug safety and efficacy when making its recommendations. The committee also considers public comments and testimony related to the drug classes being reviewed or other PDL-related agenda items.
The P&T Committee consists of 7 physicians, 4 pharmacists and 2 client representatives, who are appointed by the Department's Executive Director. Review the Policies and Procedures Manual for more information on the committee's membership, duties and policies.
Presenting testimony
Interested parties that would like to present testimony to the P&T Committee may sign up on the day of a meeting; however, the Department encourages giving advanced notice by contacting Jim Leonard, the committee coordinator, at 303-866-3502 or Jim.Leonard@state.co.us
Attention Potential P&T Committee Members
The Department is currently accepting curriculum vitae from potential P&T Committee members. If you are interested in serving or know someone who would be qualified please submit a CV along with a completed Conflict of Interest form (see bottom of this page for form) to Jim Leonard, 1570 Grant St., Denver, CO 80203, or fax to 303-866-3552 attn: Jim Leonard.
P&T Committee Next Meeting
Tuesday January 10, 2012
1:00pm - 5:00pm
225 E. 16th Avenue, 1st floor Conference Room, Denver, Colorado
